Methotrexate and prednisolone study in erythema nodosum leprosum (MaPs in ENL) protocol: a double-blind randomised clinical trial

INTRODUCTION: Erythema nodosum leprosum (ENL) is an immunological complication of leprosy. ENL results in morbidity and disability and if it is not treated can lead to death. The current treatment consists of thalidomide or high doses of oral corticosteroids for prolonged periods. Thalidomide is not...

Descripción completa

Detalles Bibliográficos
Autores principales: de Barros, Barbara, Lambert, Saba M, Shah, Mahesh, Pai, Vivek V, Darlong, Joydeepa, Rozario, Benjamin Jewel, Alinda, Medhi Denisa, Sales, Anna M, Doni, Shimelis, Hagge, Deanna A, Shrestha, Dilip, Listiawan, M. Yulianto, Yitaye, Abeba M, Nery, Jose A C, Neupane, Kapil D, Dias, Vivianne L A, Butlin, C. Ruth, Nicholls, Peter G, Lockwood, Diana, Walker, Stephen L
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Infectious Diseases
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7674097/
https://www.ncbi.nlm.nih.gov/pubmed/33203627
http://dx.doi.org/10.1136/bmjopen-2020-037700

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7674097/
https://www.ncbi.nlm.nih.gov/pubmed/33203627
http://dx.doi.org/10.1136/bmjopen-2020-037700

Ejemplares similares